USPSTF Final Recommendation Statement: Screening for Chlamydia and Gonorrhea

On September 14, 2021, the U.S. Preventive Services Task Force (USPSTF) released a final recommendation statement on screening for chlamydia and gonorrhea. USPSTF recommends screening for these infections in sexually active women and pregnant people 24 years and younger, or 25 years and older if at increased risk. There is not enough evidence to recommend for or against screening for these infections in men. As detailed by the Task Force:

• The USPSTF concludes with moderate certainty that screening for chlamydia in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection has moderate net benefit.
• The USPSTF concludes with moderate certainty that screening for gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection has moderate net benefit.
• The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men.

To view the recommendation, the evidence on which it is based, and a summary for clinicians, visit the USPSTF website. The final recommendation statement can also be found in the September 14, 2021 online issue of JAMA.